-
Mark, I appreciate you sharing all of this. It sounds incredibly exhausting and discouraging to deal with the long delays, repeated denials, and how these gaps affect your gMG symptoms. Many people in rare disease communities face similar difficulties when insurance obstacles hinder access to essential treatment.
Your insights about Medicare and supplemental plans will be valuable for others facing similar challenges. -Jodi, Patient Advocate